Stay updated with breaking news from From Genes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cereno Scientific today announced that an abstract on the preclinical drug candidate CS585 has been accepted as an oral presentation at the scientific conference Vascular Discovery... | April 21, 2023
BIO CEO & Investor Conference 2023 IASLC 2023 Targeted Therapies of Lung Cancer Meeting 16th Annual European Life Sciences CEO ForumCancer Epigenetics Institute Symposium: From Genes to Chromatin... | February 6, 2023
SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- Nuevocor, a pre-clinical stage cardiac gene therapy company, announced today that it will be presenting at the Biotech Showcase during JPM week, taking place in San Francisco, CA, USA from January 9 to 11, 2023. Nuevocor will also be giving an oral presentation on new pre-clinical data for its LMNA cardiac gene therapy...
Results from a new mouse model may aid in understanding how depression and prolonged and severe stress increase the risk of cardiovascular disease, according to preliminary research presented at the American Heart Association's Vascular Discovery: From Genes to Medicine Scientific Sessions 2022.
FXR1, a protein in the same family as the one implicated in Fragile X syndrome, is the new potential target for creating blood pressure-lowering medicine.